Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma.
Kawashima A, Uemura M, Kato T, Ujike T, Nagahara A, Fujita K, Imamura R, Yamanaka Y, Tomiyama E, Tanigawa G, Miyagawa Y, Yoshioka T, Miyake O, Nonomura N. Kawashima A, et al. Among authors: tomiyama e. Int J Clin Oncol. 2019 Jan;24(1):78-86. doi: 10.1007/s10147-018-1332-1. Epub 2018 Aug 9. Int J Clin Oncol. 2019. PMID: 30094693 Free PMC article.
[A CASE OF PROSTATE CANCER WITH SECONDARY HYPOGONADISM].
Tomiyama E, Nagahara A, Nakano K, Nakazawa S, Uemura M, Kiuchi H, Imamura R, Miyagawa Y, Minato N, Koga M, Sugao H, Nonomura N. Tomiyama E, et al. Nihon Hinyokika Gakkai Zasshi. 2017;108(4):215-219. doi: 10.5980/jpnjurol.108.215. Nihon Hinyokika Gakkai Zasshi. 2017. PMID: 30333445 Free article. Japanese.
The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer.
Ishizuya Y, Uemura M, Narumi R, Tomiyama E, Koh Y, Matsushita M, Nakano K, Hayashi Y, Wang C, Kato T, Hatano K, Kawashima A, Ujike T, Fujita K, Imamura R, Adachi J, Tomonaga T, Nonomura N. Ishizuya Y, et al. Among authors: tomiyama e. Biochem Biophys Res Commun. 2020 Mar 12;523(3):588-594. doi: 10.1016/j.bbrc.2019.12.084. Epub 2020 Jan 12. Biochem Biophys Res Commun. 2020. PMID: 31941606 Free article.
MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
Wang C, Uemura M, Tomiyama E, Matsushita M, Koh Y, Nakano K, Hayashi Y, Ishizuya Y, Jingushi K, Kato T, Hatano K, Kawashima A, Ujike T, Nagahara A, Fujita K, Imamura R, Tsujikawa K, Nonomura N. Wang C, et al. Among authors: tomiyama e. Cancer Sci. 2020 Apr;111(4):1146-1155. doi: 10.1111/cas.14325. Epub 2020 Feb 19. Cancer Sci. 2020. PMID: 31975504 Free PMC article.
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer.
Hayashi Y, Fujita K, Matsuzaki K, Eich ML, Tomiyama E, Matsushita M, Koh Y, Nakano K, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Netto GJ, Nonomura N. Hayashi Y, et al. Among authors: tomiyama e. Front Oncol. 2020 May 19;10:755. doi: 10.3389/fonc.2020.00755. eCollection 2020. Front Oncol. 2020. PMID: 32509577 Free PMC article.
TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
Hayashi Y, Fujita K, Nojima S, Tomiyama E, Matsushita M, Koh Y, Nakano K, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Morii E, Nonomura N. Hayashi Y, et al. Among authors: tomiyama e. Mol Oncol. 2020 Oct;14(10):2375-2383. doi: 10.1002/1878-0261.12746. Epub 2020 Jun 27. Mol Oncol. 2020. PMID: 32533903 Free PMC article.
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma.
Tomiyama E, Fujita K, Rodriguez Pena MDC, Taheri D, Banno E, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Takao T, Yamaguchi S, Fushimi H, Yoshimura K, Uemura H, Netto GJ, Nonomura N. Tomiyama E, et al. Int J Mol Sci. 2020 Jul 29;21(15):5390. doi: 10.3390/ijms21155390. Int J Mol Sci. 2020. PMID: 32751328 Free PMC article.
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma.
Kato T, Tomiyama E, Koh Y, Matsushita M, Hayashi Y, Nakano K, Ishizuya YU, Wang C, Hatano K, Kawashima A, Ujike T, Kawasaki K, Morii E, Gotoh K, Eguchi H, Kiyotani K, Fujita K, Nonomura N, Uemura M. Kato T, et al. Among authors: tomiyama e. Anticancer Res. 2020 Sep;40(9):4875-4883. doi: 10.21873/anticanres.14490. Anticancer Res. 2020. PMID: 32878775
57 results